Business
JCR Pharmaceuticals Marks 50 Years of Innovation with Launch of One-of-a-Kind Global Website
HYOGO, Japan, June 06, 2025--JCR Pharmaceuticals announced the launch of its new global website, as the company celebrates its 50th anniversary.
About this update from Jcr Pharmaceuticals Co., Ltd.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":251,"url":"https://media.zenfs.com/en/business-wire.com/e8299c8d7aef23035f0756ec0a3227aa"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yFK84jBsHFQF0RhOv9UsuA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUwMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/e8299c8d7aef23035f0756ec0a3227aa","width":480,"height":251}},"lazy":false},{"type":"text","content":"- A refreshed global brand signals JCR’s expanded international presence and unwavering focus on rare and genetic diseases worldwide -","length":134,"tagName":"p","attribs":{}},{"type":"text","content":"HYOGO, Japan, June 06, 2025--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the launch of its new global website. As the company turns 50, it is marking its growing footprint in Japan, the U.S., Europe, and Latin America with a unique website tailored for global audiences that reflects its passion for both science and humanity and brings the JCR brand to life for patients, physicians, and partners worldwide.","length":566,"tagName":"p"},{"type":"text","content":""At JCR, we are committed to advancing science and delivering on the treatments for patients with unmet needs around the world," said Shin Ashida, Chairman, President and CEO of JCR Pharmaceuticals. "In September, we celebrate the 50th anniversary of the company I founded in 1975. The launch of our new global website reflects our evolution from an innovative startup in Japan to a global biopharmaceutical company. We remain dedicated to developing therapies for people with rare and genetic diseases and partnering with those who share our vision of transforming care for patients and families living with once untreatable diseases."","length":656,"tagName":"p"},{"type":"text","content":"The site features streamlined user interface and curated content for patients, physicians, partners, and investors – reinforcing JCR’s commitment to bridge the gap between complex science and unmet needs of patients and families.","length":229,"tagName":"p"},{"type":"text","content":"For the past 50 years, JCR has built a rep...